Minerva Medica 2012 August;103(4)

  TARGETING: RENAL DISEASES

Minerva Medica 2012 August;103(4):219-34

2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials

Fernández Fernández B., Elewa U., Sánchez-Niño M. D., Rojas-Rivera J. E., Martin-Cleary C., Egido J., Ortiz A.

Abstract PDF

  TARGETING: RENAL DISEASES

Minerva Medica 2012 August;103(4):235-51

Recent news in the treatment of lupus nephritis

Tesar V., Hruskova Z.

Abstract PDF

  TARGETING: RENAL DISEASES

Minerva Medica 2012 August;103(4):253-66

An overview of immunosuppressive therapy in idiopathic membranous nephropathy

Maas R. J., Hofstra J. M., Wetzels J. F.

Abstract PDF

  TARGETING: RENAL DISEASES

Minerva Medica 2012 August;103(4):267-78

A primer on the epigenetics of kidney fibrosis

Mahl Tampe D., Zeisberg M.

Abstract PDF

  TARGETING: RENAL DISEASES

Minerva Medica 2012 August;103(4):279-91

An update on the current management of hyponatremia

Lindner G., Schwarz C.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Medica 2012 August;103(4):293-7

Comparison of Hepatitis C virus subtyping by ns5b sequencing with 5’utr based methods

Pagani E., Huemer H. P., Pasquetto V., Cemin C., Molon L., Rossi P., Larcher C.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Medica 2012 August;103(4):299-311

Neuroimaging and definition of transient ischemic attack

Cerase A., Lazzeretti L., Vallone I. M., Ferretti F., Bracco S., Galluzzi P., Gennari P., Monti L., Menci E., Bellini M., Arrigucci U., Cioni S., Romano D., Sanna A., Zandonella A., Acampa M., Tassi R., Martini G., Venturi C.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Medica 2012 August;103(4):313-21

Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis

Mirzaei K., Ahmadi S., Hossein-Nezhad A., Mokhtari F.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Medica 2012 August;103(4):323-9

Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome

Tabak Ö., Gelişgen R., Çicekçi H., Şenateş E., Erdenen F., Müderrisoğlu C., Aral H., Uzun H.

Abstract PDF

CORRESPONDENCE  

Minerva Medica 2012 August;103(4):331-2

Double interruption of antiplatelet therapy and tirofiban “bridging” for lung cancer resection

Conrotto F., Scacciatella P., Cristofori R., Grasso C., D’Amico M., Pennone M., Marra S.

PDF